InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Rothera Mark. Officer active across 2 companies, notably Viracta Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 30 November 2023. The latest transaction was disclosed on 30 November 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations